Form 4: Immunovant's Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark S. Levine, Chief Legal Officer of Immunovant, Inc., sold shares to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- Mark S. Levine, the Chief Legal Officer of Immunovant, Inc., reported a transaction on April 24, 2024, involving the sale of 3,963 shares of common stock.
- The shares were sold at a price of $28.9 per share.
- This sale was to cover tax withholding obligations related to the vesting of 8,937 restricted stock units (RSUs) on April 19, 2024.
- The sale was mandated by Immunovant's policy to cover tax obligations through a 'sell to cover' transaction.
- Following the transaction, Levine still beneficially owns 343,156 shares of Immunovant common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's outlook on the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This particular transaction is related to tax obligations and doesn't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 2022-01-28 | Holder was granted 143,000 restricted stock units (RSUs). |
| 2024-04-19 | 8,937 of the RSUs vested. |
| 2024-04-24 | Sale of 3,963 shares to cover tax withholding obligations. |
| 2024-04-26 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.